Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Library Archives
Volume 23, 2019 Archive

Six issues from 2019 in one convenient archive.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $30000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2019
Vol. 23 No. 1
Volume 23, Number 1
March/April 2019
Vol. 23 No. 2
Volume 23, Number 2
May/June 2019
Vol. 23 No. 3
Volume 23, Number 3
July/August 2019
Vol. 23 No. 4
Volume 23, Number 4
September/October 2019
Vol. 23 No. 5
Volume 23, Number 5
November/December 2019
Vol. 23 No. 6
Volume 23, Number 6

Volume 23, 2019 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: The Cost of Information
Allen Loyd V Jr
Jan/Feb 2019
Pg. 4

An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Selmin Francesca
, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
Jan/Feb 2019
Pg. 6-12

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
Jan/Feb 2019
Pg. 14-21

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T
, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019
Pg. 32-33

Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
Jan/Feb 2019
Pg. 35-44

Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
Jan/Feb 2019
Pg. 47-49

Calculations
Stockton Shelly J
Jan/Feb 2019
Pg. 50

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 54

Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 55

Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
Jan/Feb 2019
Pg. 56

Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 57

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Orodispersible Film
Allen Loyd V Jr
Jan/Feb 2019
Pg. 59

Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Allen Loyd V Jr
Jan/Feb 2019
Pg. 60

Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 61

Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L
, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
Jan/Feb 2019
Pg. 62-64

Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson
, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019
Pg. 65-69

Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
Jan/Feb 2019
Pg. 70-76

Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C
, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2019
Pg. 77-81

Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah
, Agu Remigius U
Jan/Feb 2019
Pg. 82-87

PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
Mar/Apr 2019
Pg. 92

Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
Mar/Apr 2019
Pg. 94-104

Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
Mar/Apr 2019
Pg. 106-111

Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
Mar/Apr 2019
Pg. 113-119

Patient Access Is a Patient Safety Issue
Pore David
Mar/Apr 2019
Pg. 120-121

Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130

Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations
Allen Loyd V Jr
Mar/Apr 2019
Pg. 135-143

Calculations
Stockton Shelly J
, Drinnon Stephen D
Mar/Apr 2019
Pg. 144

Acetaminophen 50% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 146

Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 147

Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 148

Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
Mar/Apr 2019
Pg. 149

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 150

Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2019
Pg. 151

Rosuvastatin 20 mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 152

Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 153

Towards the Importance of a Roller Mill in Compounding Practice: An Experimental Approach
Polonini Hudson
, Loures da Silva Sharlene, Batista Patrício Fernando, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Mar/Apr 2019
Pg. 154-156

Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Mar/Apr 2019
Pg. 157-162

Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit
Lardinois Benjamin
, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M
Mar/Apr 2019
Pg. 163-166

Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure
Ip Kendice
, Banov Daniel, Bassani Gus, Morgan Latisha
Mar/Apr 2019
Pg. 167-175

PreScription: Honesty/Ethics in Professions: The Gallup Polls
Allen Loyd V Jr
May/Jun 2019
Pg. 180

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

Summary of Educational Offerings Provided by Compounding Support Companies in 2019
Stevens J Tyler
May/Jun 2019
Pg. 188-191

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
May/Jun 2019
Pg. 192-199

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
May/Jun 2019
Pg. 200-207

Can We Fix It?
Brunner Scott
May/Jun 2019
Pg. 208-209

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
May/Jun 2019
Pg. 211-216

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Calculations
Stockton Shelly J
May/Jun 2019
Pg. 229

Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 230

Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 231

Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Allen Loyd V Jr
May/Jun 2019
Pg. 232

Flunisolide Nasal Spray
Allen Loyd V Jr
May/Jun 2019
Pg. 233

Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 234

Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2019
Pg. 235

Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
May/Jun 2019
Pg. 236

Valsartan 16-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 237

Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K
, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
May/Jun 2019
Pg. 238-244

Trends of Extemporaneous Drug Prescription in Latvia in 2017
Kiselova Olga
, Maurina Baiba, Sidlovska Venta, Rogovska Irena
May/Jun 2019
Pg. 245-249

Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
Rashid Mamoon
, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
May/Jun 2019
Pg. 250-257

An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability
Reindel Kristin L
, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
May/Jun 2019
Pg. 258-263

PreScription: Temperatures by Degrees
Allen Loyd V Jr
Jul/Aug 2019
Pg. 268

Contamination Control in Compounding Areas
Mulder Kyle
, Gonzales Ben A
Jul/Aug 2019
Pg. 271-278

Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Newton David W
Jul/Aug 2019
Pg. 281-287

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future
Brunner Scott
Jul/Aug 2019
Pg. 294-296

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
Jul/Aug 2019
Pg. 299-303

Basics: Excipients Used in Nonsterile Compounding, Part 1
Allen Loyd V Jr
Jul/Aug 2019
Pg. 305-311

Calculations
Stockton Shelly J
, Drinnon Stephen D
Jul/Aug 2019
Pg. 312-313

Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Allen Loyd V Jr
Jul/Aug 2019
Pg. 314

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
Jul/Aug 2019
Pg. 315

Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2019
Pg. 316

Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
Jul/Aug 2019
Pg. 317

Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
Jul/Aug 2019
Pg. 318

Rifampin 25 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2019
Pg. 319

Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin
, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2019
Pg. 320-323

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina
, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jul/Aug 2019
Pg. 324-331

Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L
, York Anne E
Jul/Aug 2019
Pg. 325-339

Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches
Burrows Anna C
, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L
Jul/Aug 2019
Pg. 340-350

Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.
Jul/Aug 2019
Pg. 351

Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249.
Jul/Aug 2019
Pg. 351

PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc
Allen Loyd V Jr
Sep/Oct 2019
Pg. 356

Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George
, Daleo Charles, Batson SL
Sep/Oct 2019
Pg. 358-364

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
Sep/Oct 2019
Pg. 376-381

Threading the Needle
Brunner Scott
Sep/Oct 2019
Pg. 383-385

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019
Pg. 387-391

Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
Sep/Oct 2019
Pg. 393-396

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Calculations
Stockton Shelly J
Sep/Oct 2019
Pg. 404

Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 406

Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 407

Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 408

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 409

Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2019
Pg. 410

Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
Sep/Oct 2019
Pg. 411

Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
Sep/Oct 2019
Pg. 412

Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 413

Stability of Furosemide 5 mg/mL in Polypropylene Syringes
van der Schaar JAJ
, Grouls R, Franssen EJF, Crul M
Sep/Oct 2019
Pg. 414-417

Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Berisa Prado Silvia
, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Sep/Oct 2019
Pg. 418-421

The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E
, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Sep/Oct 2019
Pg. 422-427

The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E
, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019
Pg. 428-433

Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics
Lardinois Benjamin
, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Sep/Oct 2019
Pg. 434-437

Erratum: McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospice patient with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe : A case report. IJPC. 2012; 16(5): 364–368.
Sep/Oct 2019
Pg. 438

Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191.
Sep/Oct 2019
Pg. 438

PreScription: As Things Change….
Allen Loyd V Jr
Nov/Dec 2019
Pg. 444

Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
Nov/Dec 2019
Pg. 447-452

How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A
, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019
Pg. 454-461

Are You Part of the Solution or Part of the Problem?
Brunner Scott
Nov/Dec 2019
Pg. 462-464

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019
Pg. 467-471

Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
Nov/Dec 2019
Pg. 472-477

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Calculations
Stockton Shelly J
, Stover Emily M
Nov/Dec 2019
Pg. 484

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 486

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 489

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 491

Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Nov/Dec 2019
Pg. 492

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 493

Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
Nov/Dec 2019
Pg. 494

Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 495

Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah
, Agu Remigius U
Nov/Dec 2019
Pg. 496-503

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad
, Day A J
Nov/Dec 2019
Pg. 511-518

Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt
Graves Richard A
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
Nov/Dec 2019
Pg. 519-527

Return to Top